Unprotected left main coronary disease and ST-segment elevation myocardial infarction: a contemporary review and

Michael S Lee1, Pooya Bokhoor, Seung-Jung Park

  • 1UCLA Medical Center, Los Angeles, California 90095, USA. mslee@mednet.ucla.edu

Insights

Percutaneous coronary intervention (PCI) offers rapid reperfusion for unprotected left main coronary artery (ULMCA) occlusions during myocardial infarction (MI). This approach is a viable alternative to bypass surgery for selected high-risk patients, prioritizing survival.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • Unprotected left main coronary artery (ULMCA) occlusion is a critical event with high mortality.
  • Optimal revascularization strategy for ST-elevation myocardial infarction (MI) with ULMCA occlusion remains uncertain.
  • Coronary artery bypass grafting (CABG) is standard for stable disease, but guidelines for acute MI are vague.

Purpose of the Study:

  • To evaluate percutaneous coronary intervention (PCI) as an alternative to CABG for ULMCA occlusion in acute MI.
  • To determine the feasibility and outcomes of PCI in this high-risk patient group.
  • To inform treatment guidelines for ULMCA occlusion during MI.

Main Methods:

  • Review of clinical data and outcomes for patients with ULMCA occlusion and MI.
  • Comparison of PCI versus CABG strategies in selected patient cohorts.
  • Assessment of reperfusion times, short-term, and long-term outcomes, including stroke and target vessel revascularization.

Main Results:

  • PCI is technically feasible and provides faster reperfusion than CABG for ULMCA occlusion in MI.
  • PCI is associated with acceptable short- and long-term outcomes and a lower stroke risk compared to CABG.
  • Higher rates of target vessel revascularization with PCI are noted but considered acceptable.

Conclusions:

  • PCI should be considered a viable alternative to CABG for selected MI patients with ULMCA occlusion.
  • Key indications for considering PCI include poor coronary flow, cardiogenic shock, arrhythmias, and comorbidities.
  • Rapid reperfusion via PCI is crucial for enhancing survival in acute ULMCA occlusion.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...